chrisvoncsefalvay/vaers-outcomes huggingface dataset:
made us sick as dogs; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (Patient's Mother and Father) and pain (Family History) (Patient's Mother and Father).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   The reporter considered the sickness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 31-JUL-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingles vaccine and it made felt sick as dogs but so worth it in the long run. The patient stated that just pray he/she never had to now. Additional supportive information: The follow-up would not possible, as no contact, details were available. This case is linked with case US2022AMR119005, reported by the same reporter.
Patient complaint of throat and tongue itching.  BP 152/92 P-73 Sp02 98%.  Gave 50mg of Benadryl.  Monitored patient for 40 minutes, signs and symptoms resolved.  Patient discharged in stable condition with spouse driving patient home in private vehicle.
Her arm is itchy; Her arm is red, there is a red spot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Her arm is itchy) and ERYTHEMA (Her arm is red, there is a red spot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (Her arm is itchy) and ERYTHEMA (Her arm is red, there is a red spot). At the time of the report, PRURITUS (Her arm is itchy) and ERYTHEMA (Her arm is red, there is a red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  The patient did not take any treatment medication.
migraine; slight burning in chest; body aches; warm/hot feeling on arm where the dose was administered; nauteous feeling; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 16:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient previously received  first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 17:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation and Buckwheat. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 06:00 the patient experienced migraine, slight burning in chest, body aches, warm/hot feeling on arm where the dose was administered, nauseous feeling which lasted most of the day, until around 19:00. The clinical outcome of the events migraine, slight burning in chest, body aches, warm/hot feeling on arm where the dose was administered and nauseous feeling was recovered on 01May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
bones aching; dizzy; no kind of energy; a slight headache; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache) and CHILLS (Chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information provided. No Treatment information provided.
1st Vaccine: (Took Children's Benadryl and Ibuprofen 800/Tylenol 500) Had numbness of arm and half of the face, took more Benadryl and numbness went away same day by the end of the day. Severe headache, I had them even with Ibuprofen and Tylenol started the second day/ lasted for 2 days.  Third day diarrhea all day, fourth day nausea for five days/poor appetite.  2nd Vaccine (today is the second day) (took Children's Benadryl 12.5mg, Loratedine 10mg) Had numbness or face within 15 minutes lasted about 3 hours (took adult Benadryl 25mg) Doctor had me on observation before leaving. Second day mid day, facial numbness started again, (took an adult Benadryl 25mg three hours later feels better. Started diarrhea.
patient fainted about 7 minutes after his shot at the clinic. he was sitting and fainted in his seat. The nurse and pharmacists rushed over right away and he was barely responding. his tongue and lips were seen to be swelling. The nurse administered the auvi-q right away and less than a minute, the patient came back and was confused about what happened. he started sweating and his tongue and lips came back to normal. he was monitored for about an hour - he called his doctor because he refused to go to the hospital. his doctor assured he would be okay after being monitored an hour, said to take benadryl around the clock and call 911 if anything happens. patient agreed
Woke in night and seemed to be confused and disoriented then had a seizure.  Called ambulance and was taken to Hospital where they said he had had a small vascular stroke and two seizures.  Was in Hospital for one week and skilled nursing for two weeks because he tested positive to Covid and had to be quarantined.   He isn't quite the same now as the new medication and whole ordeal took its toll on him considering his age.
6 month old received Bexsero; This case was reported by a consumer and described the occurrence of inappropriate age at vaccine administration in a 6-month-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd December 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 2nd December 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 04-DEC-2022 Reporter's comment: The reporter stated that 6 month old baby was mistakenly administered one dose of bexsero in her thigh. The reporter stated the patient did not had any visible adverse reactions, but were hoping to speak to someone about the incident as physician's office was not been very helpful. Additional Supportive Information: The six month old patient received a dose of Bexsero which led to inappropriate age at vaccine administration.
Cough Congestion Uncontrollable urge to sleep body aches  slept for 3 days after still dealing with lingering effects
No reaction. This vaccine was given after the beyond use by date. It was in the refrigerator past the 10 weeks recommended storage time.
This spontaneous case reported by a consumer, describes the occurrence of ear discomfort (fluid in ear), influenza (felt like the flu), hyperhidrosis (broke into a sweat porously), fatigue (very tired) and pyrexia (102 temp) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced ear discomfort (fluid in ear), influenza (felt like the flu), hyperhidrosis (broke into a sweat porously), fatigue (very tired) and pyrexia (102 temp), had a terrible headache and chills (freezing/chills). At the time of the report, ear discomfort (fluid in ear), influenza (felt like the flu), hyperhidrosis (broke into a sweat porously), fatigue (very tired) and pyrexia (102 temp), had a terrible headache and chills (freezing/chills) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. This case linked to MOD-2021-065271 and MOD-2021-065300 (patient link). Reporter did not allow further contact.
Information has been received from a health professional concerning a 48 year old female who on 14-NOV-2006 at 09:45 am was vaccinated with Pneumovax 23 (lot #651148/0087F), IM in the left deltoid and influenza virus vaccine (unspecified) (lot #AFLMA237), IM in the right deltoid (number of previous doses 15+).  Concomitant therapy was not reported.  On 14-NOV-2006, at approximately 09:52 am, the patient became flushed, mottled and heart rate was 96.  The patient then complained of heart palpitations, chest tightness, lightheadedness and shortness of breath.  Subsequently, the patient began feeling better approximately 5-10 minutes later.  The patient took BENADRYL, 25 mg by mouth.  The patient remained at work and returned to the flu shot site without any complaints.  The patient's skin was normal color, there was no rash or redness.  The patient denied chest heaviness or shortness of breath.  The patient recovered on 14-NOV-2006.  Additional information has been requested.
I received my 2nd Moderna shot 10/19/21 after a long delay.  First one was on 4/28/21.  I had delayed due to ear ringing for nearly two months.  I had reported this via agency id. No one followed up with me.  I had decided to not get the 2nd shot due to the terrible experience and that no one cared enough to follow up with me.  I was given no choice by my employer recently to be 'fully' vaccinated.    My second experience has been bad too.  I opt'd to delay reporting to you to give this time to play out.  Ear ringing is a factor again but the length of severe ear ringing seems to be less (so far).  I am at 3 weeks now since the shot.  I did experience significant side effects beginning 24-36hrs after the shot.  My blood pressure and pulse went up for a period of 4 days. My heart was 'pounding' non-stop during that time.  I had a difficult time sleeping at all and I lost 7-8 pounds.  I have only gain a fraction of the weight back.  During that time my systolic pressure was up 25-30 and diastolic up 10-15.  The pulse was up 10-15.  Along with this I had bad ear ringing (due to blood pressure being up?), head and ear pressure, dulled thinking and terrible short term memory, headache and wooziness.  I wonder if Moderna is too powerful for my body.  I do have a marginal thyroid.  This could be the factor that makes me have a significantly less comfortable experience.  The other possibility is that my immune response is very high.  Either way, I need other options.  The Agency needs to start widening the consideration to people like me to provide the additional options and leeway while you all figure this out.  I am 65 years old as of 10/15.  BTW, I also followed up via phone (agency) prior to the second shot and still no one  contacted me.
Large axillary lymphadenopathy, the size of a softball, and peripheral neuropathy in distribution of the ulnar nerve
This spontaneous report as received from a nurse refers to a patient of unknown age. On 09-APR-2014 the patient was vaccinated with an expired dose of ROTATEQ (lot # H017721, exp. date: 01-APR-2014, 2 ml, route of administration-oral). No adverse effects reported. Additional information has been requested.
Syncopal Episode EKG (-) results Pt.observed by EMT for 30 additional minutes. Given something to eat. Sent home @13:10 Seen by EMT on site.
never got the second shot; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix 5 years ago from reporting).   On an unknown date, the patient receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 04-Apr-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient reported that he/she never got second shot of Shingrix. Additional Supportive Information:  Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.
Very dizzy; disoriented; tingling in fingers, hands, feet; Difficulty walking; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 18:00, after 435 minutes of vaccination, the patient experienced very dizzy, disoriented, tingling in fingers, hands, feet and difficulty in walking. It was unknown if the patient received treatment for the reported events. The events did result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events very dizzy, disoriented, tingling in fingers, hands, feet and difficulty in walking were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse concerning a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 30-MAR-2016 the patient was vaccinated with a dose of expired RECOMBIVAX HB (dose, unit and route not reported, lot # K019502 with EXP. date 04-FEB-2016, also reported as 04-FEB-2015). No adverse effect was reported. Additional information has been requested.
Inadvertent adminsitration of 2 doses of H1N1 influenza vaccine
Patient required 2 injections; 1st injection given with no flu vaccine in syringe; 2nd injection had flu vaccine drawn up - was given.
female with history of diabetes anxiety hypertension presents to the emergency department no acute distress by EMS from home.  Her blood sugar was low.  Earlier today I got a call from her for some coughing and shortness of breath.  She refused to come to the emergency department at that time.  She states she has had some cough and congestion for the past couple days.  No chest pain.  No fever.  She is awake and alert on arrival.  She states she is not sure if she took her Lantus 40 units nighttime dose.
Pt c/o feeling lightheaded s/p 2nd moderna vaccine. Vital signs stable BP 140/70, HR 58, RR 14. Exam provided. Pt reported feeling "off-balance and unsteady" when standing. Provider recommended that she go to ER immediately with ambulance. Pt and daughter refused.
Patient had received the vaccine day prior to coming to ED. Presented to ED with family due to n/v/chills with shaking.  She was able to dress self into gown and answer history questions.   Then when she laid supine she became cold/clammy with loss of pulse.  CPR was started with eventual decision by family to cease.
This spontaneous report as received from medical assistant and refers to unspecified patients of unknown ages and genders. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. Since 11-JAN-2017, the patients were vaccinated with doses of improperly stored PROQUAD lot # M022400 and expiration date: 01-NOV-2017 (route, dosage schedule were not reported) for prophylaxis. Nevertheless, no adverse effects were reported. The administered doses of vaccine experienced a temperature excursion of more than 5 grades F (Fahrenheit) but less than 14 grades F for 2 hours and 30 minutes, and more than 14 grades F but less than 46 grades F for 12 hours and 15 minutes. Data logger was involved and there was no previous temperature excursion reported. Furthermore, no product quality complaint (PQC) was involved. Additional information has been requested.; Sender's Comments:  US-009507513-1701USA013144:
patient reports within the first 24 hours of receiving the TDAP patient had extreme pain in left arm that radiates to neck down to fingers- patient has been having spasms. Patient saw Chiro- stated that it relieved the pain slightly and massages help as well. Patient has been taking advil as well as a hot pack when pain is not tolerable that helps. Patient scheduled to be evaluated
teeth chattering chills, fever, severe headache, muscle aches; teeth chattering chills, fever, severe headache, muscle aches; teeth chattering chills, fever, severe headache, muscle aches; teeth chattering chills, fever, severe headache, muscle aches; This is a spontaneous report from a contactable consumer or other non hcp. A 65-years-old non-pregnant female patient received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 23Feb2021 10:30(age at vaccination: 65 years) as DOSE 2, SINGLE for covid-19 immunisation. Patient was not pregnant at the time of vaccination, patient didn't receive other vaccines within 4weeks prior to vaccination. Patient had received other medications Zyrtec, Vitamin D3 within 2weeks of vaccination. Patient didn't had covid prior to vaccination. The patient medical history was not reported. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. Patient had no allergies. Patient previously received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: unknown) via unspecified route of administration in Arm left on 03Feb2021 10:30 (age at vaccination:65 years) as DOSE 1, SINGLE for covid-19 immunisation. On 23Feb2021 23:00 the patient experienced teeth chattering chills, fever, severe headache, muscle aches. No therapeutic measures were taken for the events. Patient was not tested for covid to post vaccination. The outcome of the events chills, pyrexia, headache, myalgia was recovered.  No follow-up attempts are possible. No further information is expected.
nausea; sore arm; chills; exhausted; feeling hot; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 15th January 2020).   On 15th July 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 15th July 2020, 8 hrs after receiving Shingrix, the patient experienced pain in arm, chills, exhaustion and feeling hot. On 16th July 2020, the patient experienced nausea. On an unknown date, the outcome of the nausea, pain in arm, chills, exhaustion and feeling hot were unknown.   It was unknown if the reporter considered the nausea, pain in arm, chills, exhaustion and feeling hot to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix on 15th January 2020, and reported no adverse events.  After receiving the 2nd dose of Shingrix the patient the patient experienced sore arm, feeling hot, feeling exhausted, has chills, and 1 day after vaccination the patient experienced nausea. The reporter did not consent to follow up.
PATIENT WAS WAITING IN THE LOBBY FOR HER RIDE AFTER RECEIVING VACCINE, AND REPORTED TO THE FRONT DESK THAT SHE WAS HAVING ISSUES WITH HER THROAT SWELLING.  THE CLINIC ADMIN PRESENTED TO THE PHARMACY WINDOW AND INFORMED THE PHARMACY.  THE PATIENT WAS TAKEN INTO THE CONSULTATION ROOM AND I INFORMED HER SHE WOULD BE GETTING BENADRYL AND EPI-PEN, A BIT RELECTANT I MESSAGED HER PCP IN HOUSE AND HE CAME OVER AND INFORMED HER ABOUT ME DOING THIS TO SAVE HER LIFE, WORST CASE SCENARIO.  I GAVE HER BENADRYL 25MG WITH WATER THEN ADMINISTERED ONLY 1 EPI PEN 0.3MG.  PCP AND I THE PAHRMACIST STAYED BY HER SIDE UNTIL SHE WAS COHERENT, DID NOT REQUIRE A 2ND DOSE, BUT WAS MOVED OUT TO BE OBSERVED BY THE CLINIC IN A WHEEL CHAIR.  SHE WAS UP AND SNACKING IN NO TIME, AND WAITED A BIT LONGER TO RECIEVE A RIDE.
observed patient have a seizure while in waiting area, about 5 minutes after receiving vaccine, ambulance was called